New effort aims to improve pharmaceutical supply chain efficiency for ocean logistics
Peli BioThermal, the global name in temperature controlled packaging, has announced their founding membership in Poseidon. Poseidon is a sea freight model acknowledging and supporting the intimate interconnection of the entire pharma-logistics supply chain in order to better ensure the safe and secure transportation of health-giving and life-saving pharmaceutical products.
Peli BioThermal is one of a select number of industry leaders hand-picked to join the newly launched sea-freight program. Poseidon is focused on improving collaboration and integration between pharmaceutical manufacturers and their logistics solution providers.
“The pharmaceutical industry, as a whole, is looking to sea freight for a carbon-friendly, efficient use of fuels,” said Peli BioThermal director of worldwide marketing, Adam Tetz. “Joining Poseidon allows us to work together with industry leaders to outline how ocean transport can best be utilised to improve the efficiency of that channel for the pharmaceutical supply chain.” Poseidon provides a sea-freight GDP compliant model, aimed at ensuring the safe and secure transportation of pharmaceutical products throughout the entire pharma-logistics supply chain. The program focuses on an ocean-going approach to temperature controlled pharmaceutical transportation, which offers low transportation costs, minimal environmental impact and minimised temperature excursions during long-haul logistics.
Peli BioThermal’s involvement as a founding member of Poseidon comes on the heels of the announcement regarding worldwide expansion of the company’s Crēdo on Demand rental program, including the launch of a dozen new service centres and more than 50 drop-off points during 2018.Visit www.pelibiothermal.com to learn more about the wide range of Peli BioThermal products and offerings.
Peli BioThermal is a division of Peli Products, S.L.U., which is the European arm of Pelican Products, Inc., a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco. ###